Navigation Links
Xanodyne Announces Planned President & CEO Succession
Date:5/27/2010

NEWPORT, Ky., May 27 /PRNewswire/ -- Xanodyne Pharmaceuticals, Inc. is pleased to announce that Natasha Giordano has been named to the position of President and Chief Executive Officer and will be elected to the Company's Board of Directors, succeeding Michael J. Valentino.

The management transition was planned by the Board and follows a year of significant new product and commercial successes under Mr. Valentino's leadership.  In 2009, Xanodyne received FDA approval for Zipsor®, a new treatment option indicated for relief of mild to moderate acute pain in adults.  The Company also received FDA approval for Lysteda™ indicated for treatment of women suffering from cyclic heavy menstrual bleeding (HMB), also known as menorrhagia.  Recently, Xanodyne announced that is has tightly focused the strategic direction for the company on the pain management market, and the related sale of Lysteda™ to Ferring Pharmaceuticals.  Xanodyne has a strategic partnership with Ferring for the co-promotion of Zipsor®.

Ms. Giordano most recently served as the company's Chief Operating Officer during this period of unprecedented success.  Ms. Giordano has more than 25 years of experience in the healthcare and pharmaceutical industry and prior to Xanodyne served as President Americas at Cegedim Dendrite, a global sales and marketing solutions and information company specializing in the pharmaceutical industry.  Her depth of experience includes senior leadership positions in general management, marketing, compliance, and sales at major pharmaceutical companies including Pfizer and Parke-Davis.

Ms. Giordano said, "I look forward to working with the Board and management team in continuing to drive toward our
'/>"/>

SOURCE Xanodyne Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Ferring Acquires LYSTEDA(TM) From Xanodyne Pharmaceuticals, Inc.
2. Xanodyne Announces Renewed Focus on Pain Management Market
3. Xanodyne Expands U.S. Sales Force and Launches Zipsor(TM) (diclofenac potassium) Liquid Filled Capsules
4. Xanodyne Raises $50 Million in Equity Financing to Support Emerging Product Portfolio
5. CSL Behring Announces Completion of National Marketing Authorizations of Berinert® After MRP in 23 European Countries
6. China Yongxin Pharmaceuticals Announces 1-for-12 Reverse Stock Split
7. Amira Announces Second DP2 Antagonist Patent Grant in the United Kingdom
8. Horizon Pharma, Inc. Announces FDA Acceptance of DUEXA(R) New Drug Application for Filing
9. Renhuang Announces Successful Preliminary Review of Its Patent Application for Schisandra Total Lignin Extraction Method
10. FDA Announces Collaboration With Drugs.com
11. VisEn Announces New ProSense® 750 FAST and Neutrophil Elastase™ 680 FAST Fluorescence Molecular Imaging Agents at European Molecular Imaging Meeting 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... Ore. , Aug. 29, 2014 /PRNewswire-iReach/ -- ... Accessory (Axilla) Strap for the SAM Junctional Tourniquet.  ... SAM Medical Products announced today ... voluntary recall to address a potential issue with ... used for the Axilla application of the SAM ...
(Date:8/29/2014)... PLEASANTON, Calif. , Aug. 29, 2014 ... leader in device-based mechanical circulatory support therapies to save, ... be participating in the 2014 Morgan Stanley Global Healthcare ... F. Burbach , President and Chief Executive Officer, will ... p.m., Eastern Daylight Time (9:55 a.m., Pacific Daylight Time). ...
(Date:8/29/2014)... , August 29, 2014 ... Oil Market by Extraction type (SFE, Cold Pressed, ... Personal Care, Pharmaceutical, Food Supplements, Fragrance, & Others) - ... MarketsandMarkets, defines and segments the Amaranth Seed Oil ... market size in terms of value. The Amaranth ...
Breaking Medicine Technology:SAM Medical Products Implements Voluntary Recall of its Accessory (Axilla) Strap for the SAM Junctional Tourniquet. 2Amaranth Seed Oil Market worth $700.6 Million by 2019 2Amaranth Seed Oil Market worth $700.6 Million by 2019 3Amaranth Seed Oil Market worth $700.6 Million by 2019 4
... The two most,prevalent forms of genetic mental retardation, ... cause, according to researchers at,Stanford University School of ... brain, may also be associated with,autism., Although the ... result for the brain seems to be the ...
... YORK--(BUSINESS WIRE)--Apr 12, 2007 - INNOVIVE Pharmaceuticals,Inc. ... of INNO-406, a potent oral dual Bcr-Abl ... leukemia, will be presented at the American ... takes place April,14-18, 2007 at the Los ...
Cached Medicine Technology:Fragile X, Down Syndromes Linked to Faulty Brain Communication,Stanford Researcher Finds 2Fragile X, Down Syndromes Linked to Faulty Brain Communication,Stanford Researcher Finds 3Fragile X, Down Syndromes Linked to Faulty Brain Communication,Stanford Researcher Finds 4Innovive Pharmaceuticals Announces Additional Data Presentations at,American Association for Cancer Research Annual Meeting 2
(Date:8/30/2014)... As the economy continues to recover ... style bathrooms and in-home fitness centers, the North ... in interest not only in designing and installing saunas ... benefits of sauna. Through working with manufacturers across ... Sauna Society provides a strong knowledge base of Finnish ...
(Date:8/30/2014)... August 31, 2014 Atlanta based automotive ... to help raise money and awareness for ALS by ... General Managers, staff, and even Vice President Jimmy Ellis ... film and can be viewed on their Youtube page; ... the challenge, general managers and staff also took the ...
(Date:8/30/2014)... August 31, 2014 Recently, iFitDress.com, one ... its new designs of classy bridesmaid dresses . ... discounts (from 22 percent off to 62 percent off) ... extremely beautiful items. , True enough, iFitDress.com is ... special occasion gowns. The company persists in making trendy ...
(Date:8/30/2014)... (PRWEB) August 30, 2014 According to ... a decision that requires Takeda Pharmaceutical Co. and Eli ... damages for claims that the drugmakers concealed information about ... medication Actos. The case, Allen v. Takeda Pharmaceuticals North ... Court, Western District of Louisiana (Lafayette).* , According to ...
(Date:8/30/2014)... 2014 Information supplied by insurance companies ... better prices to consumers in 2014. A group of ... when using the open system for adults at ... to use this year can help the average person ... location and not from medical histories. The finder tool ...
Breaking Medicine News(10 mins):Health News:As Interest in Saunas Increases, the North American Sauna Society Increases Outreach to Provide Education on History, Design, and Culture 2Health News:Jim Ellis Automotive Group Take the ALS Ice Bucket Challenge 2Health News:Classy Bridesmaid Dresses Announced By Loved Online Supplier iFitDress.com 2Health News:The Law Office of Melinda J. Helbock A.P.C. Comments on Decision to Uphold $9 Billion Actos Award 2Health News:Term Life Insurance Rates Now Found Nationally by New Insurer Finder Tool 2
... PALO ALTO, Calif. , Jan. 27 CPI International, ... the first fiscal quarter ended January 1, 2010 , with the ... to issue a press release regarding its financial results for the quarter ...  CPI International will hold a telephonic conference call in conjunction with this ...
... survivors who had brain or other central nervous system ... the general public, according to an article published online ... Cancer Institute . This study was undertaken because ... were small, had contradictory findings, or were not population-based. ...
... Heart + Lung Institute at St. Paul,s Hospital and the ... options for abdominal aortic aneurysms (AAA) a potentially fatal ... aneurysm is a bulging of the aorta, the largest blood ... rapid blood loss and a high risk of death. About ...
... advanced and severe complications from diabetes, according to a ... Washington. These complications include kidney failure or blindness, the ... vessel problems leading to heart attack or stroke. ... Care, a scientific journal of the American Diabetes ...
... of bullying continues to be a problem among today,s ... violence, it is more prevalent in children that are ... to further their understanding of bullying, research shows a ... harmful activity. A new study conducted by ...
... higher cost-sharing for outpatient visits may increase overall spending ... for doctor visits and other outpatient care reduces seniors, ... the unintended consequence of sharply increasing hospitalizations, a new ... inflating overall health-care spending and put vulnerable elderly at ...
Cached Medicine News:Health News:CPI International to Announce First Quarter 2010 Financial Results 2Health News:CPI International to Announce First Quarter 2010 Financial Results 3Health News:Discovery points way for new treatment for aneurysms: UBC-Providence Research 2Health News:Severe complications of diabetes higher in depressed patients 2Health News:Study examines sexual orientation and bullying among adolescents 2Health News:Raising Co-Pays for Doctor Visits Raises Seniors' Hospital Use 2Health News:Raising Co-Pays for Doctor Visits Raises Seniors' Hospital Use 3
... (IFA) test for the detection and semi-quantitation ... Louis Encephalitis virus (SLE), Western Equine Encephalitis ... and California Encephalitis/La Crosse virus (CE). Each ... individual spots of SLE, WEE, EEE, and ...
... Indirect immunofluorescent antibody (IFA) ... and semi-quantitation of human ... Epstein-Barr viral capsid antigen ... ten 12-well slides, FITC ...
... immunofluorescent (ACIF) antibody test ... semi-quantitation of human serum ... antigens of Epstein-Barr virus ... ten 12-well slides, EBNA ...
... DonJoy SpinaLogic is a portable, battery-powered, micro-controlled, ... adjunct electromagnetic treatment to primary lumbar spinal ... This treatment has been shown in ... healing process begin working. Clinical studies have ...
Medicine Products: